{"id":"https://openalex.org/W1995249085","doi":"https://doi.org/10.3371/csrp.6.3.4","title":"New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia: Are We Making Real Progress?","display_name":"New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia: Are We Making Real Progress?","publication_year":2012,"publication_date":"2012-09-25","ids":{"openalex":"https://openalex.org/W1995249085","doi":"https://doi.org/10.3371/csrp.6.3.4","mag":"1995249085","pmid":"https://pubmed.ncbi.nlm.nih.gov/23006237"},"language":"en","primary_location":{"id":"doi:10.3371/csrp.6.3.4","doi":"https://doi.org/10.3371/csrp.6.3.4","is_oa":false,"landing_page_url":"https://doi.org/10.3371/csrp.6.3.4","pdf_url":null,"source":{"id":"https://openalex.org/S109175786","display_name":"Clinical Schizophrenia & Related Psychoses","issn_l":"1935-1232","issn":["1935-1232","1941-2010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-70"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Schizophrenia & Related Psychoses","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064499343","display_name":"Nobumi Miyake","orcid":"https://orcid.org/0000-0001-8694-5643","observed_orcids":["https://orcid.org/0000-0001-8694-5643"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nobumi Miyake","raw_affiliation_strings":["Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY, USA","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021387749","display_name":"Seiya Miyamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163917720","display_name":"St. Marianna University School of Medicine","ror":"https://ror.org/043axf581","country_code":"JP","type":"education","lineage":["https://openalex.org/I163917720"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seiya Miyamoto","raw_affiliation_strings":["St. Marianna Univ. Sch. of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Marianna Univ. Sch. of Medicine","institution_ids":["https://openalex.org/I163917720"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029626538","display_name":"L. Fredrik Jarskog","orcid":"https://orcid.org/0000-0001-6296-3767","observed_orcids":["https://orcid.org/0000-0001-6296-3767"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Fredrik Jarskog","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7435,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.88595351,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":"3","first_page":"122","last_page":"133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.871999979019165},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9459999799728394},{"id":"https://openalex.org/keywords/5-ht2a-receptor-antagonism","display_name":"5-HT2A receptor antagonism","score":0.9509999752044678},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonism","display_name":"dopamine D2 receptor antagonism","score":0.921999990940094},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9380000233650208},{"id":"https://openalex.org/keywords/paliperidone","display_name":"paliperidone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/asenapine","display_name":"asenapine","score":1.0},{"id":"https://openalex.org/keywords/iloperidone","display_name":"iloperidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lurasidone","display_name":"lurasidone","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/antipsychotic-tolerability","display_name":"antipsychotic tolerability","score":0.8709999918937683},{"id":"https://openalex.org/keywords/metabolic-side-effects","display_name":"metabolic side effects","score":0.8949999809265137},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.7560662031173706},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7411874532699585},{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.7131770849227905},{"id":"https://openalex.org/C2779626651","wikidata":"https://www.wikidata.org/wiki/Q416545","display_name":"Asenapine","level":4,"score":0.5489889979362488},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5263603925704956},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5194118022918701},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5138852596282959},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.5034062266349792},{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.425055593252182},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.424777090549469},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4224478602409363},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4175901412963867},{"id":"https://openalex.org/C170457331","wikidata":"https://www.wikidata.org/wiki/Q1242622","display_name":"Dopamine hypothesis of schizophrenia","level":4,"score":0.41082531213760376},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.40564990043640137},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3757227957248688},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2598375678062439},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19619661569595337}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3371/csrp.6.3.4","doi":"https://doi.org/10.3371/csrp.6.3.4","is_oa":false,"landing_page_url":"https://doi.org/10.3371/csrp.6.3.4","pdf_url":null,"source":{"id":"https://openalex.org/S109175786","display_name":"Clinical Schizophrenia & Related Psychoses","issn_l":"1935-1232","issn":["1935-1232","1941-2010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-70"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Schizophrenia & Related Psychoses","raw_type":"journal-article"},{"id":"pmid:23006237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23006237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical schizophrenia & related psychoses","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":84,"referenced_works":["https://openalex.org/W14947124","https://openalex.org/W50693228","https://openalex.org/W95266284","https://openalex.org/W1495797590","https://openalex.org/W1496912268","https://openalex.org/W1526421009","https://openalex.org/W1710169825","https://openalex.org/W1755851585","https://openalex.org/W1834529319","https://openalex.org/W1839220452","https://openalex.org/W1934926274","https://openalex.org/W1944617386","https://openalex.org/W1963935327","https://openalex.org/W1964684914","https://openalex.org/W1965085115","https://openalex.org/W1968011805","https://openalex.org/W1971179661","https://openalex.org/W1971184880","https://openalex.org/W1972159732","https://openalex.org/W1973117280","https://openalex.org/W1973852234","https://openalex.org/W1977425797","https://openalex.org/W1979700184","https://openalex.org/W1980980884","https://openalex.org/W1985766458","https://openalex.org/W1990014261","https://openalex.org/W1992181956","https://openalex.org/W1993729360","https://openalex.org/W1995219138","https://openalex.org/W1996270991","https://openalex.org/W1998327293","https://openalex.org/W2000169164","https://openalex.org/W2000406055","https://openalex.org/W2009052798","https://openalex.org/W2009577021","https://openalex.org/W2012183345","https://openalex.org/W2012720659","https://openalex.org/W2016437478","https://openalex.org/W2020995975","https://openalex.org/W2022808342","https://openalex.org/W2023577040","https://openalex.org/W2028840707","https://openalex.org/W2032902988","https://openalex.org/W2033470111","https://openalex.org/W2033545679","https://openalex.org/W2037746562","https://openalex.org/W2041376702","https://openalex.org/W2049842299","https://openalex.org/W2052765108","https://openalex.org/W2057430839","https://openalex.org/W2059022874","https://openalex.org/W2062307942","https://openalex.org/W2064036552","https://openalex.org/W2065001844","https://openalex.org/W2066640528","https://openalex.org/W2067345113","https://openalex.org/W2070357412","https://openalex.org/W2072007028","https://openalex.org/W2075321548","https://openalex.org/W2077604455","https://openalex.org/W2078053761","https://openalex.org/W2085360366","https://openalex.org/W2088504031","https://openalex.org/W2093286170","https://openalex.org/W2095927831","https://openalex.org/W2100557888","https://openalex.org/W2109196233","https://openalex.org/W2111913133","https://openalex.org/W2114801996","https://openalex.org/W2131658797","https://openalex.org/W2132980997","https://openalex.org/W2145422971","https://openalex.org/W2147015928","https://openalex.org/W2151687739","https://openalex.org/W2152770536","https://openalex.org/W2154942897","https://openalex.org/W2157007129","https://openalex.org/W2159155203","https://openalex.org/W2166256285","https://openalex.org/W2170792659","https://openalex.org/W2394925442","https://openalex.org/W2460731912","https://openalex.org/W3188767085","https://openalex.org/W4211153706"],"related_works":["https://openalex.org/W2068731941","https://openalex.org/W2009904820","https://openalex.org/W4312579605","https://openalex.org/W2016043182","https://openalex.org/W2074819429","https://openalex.org/W2032925034","https://openalex.org/W1987249329","https://openalex.org/W2078990624","https://openalex.org/W2027949421","https://openalex.org/W2093127494"],"abstract_inverted_index":{"The":[0,182],"introduction":[1],"of":[2,19,66,75,184,225,235],"second-generation":[3],"antipsychotics":[4,228],"(SGAs),":[5],"heralded":[6],"by":[7,85],"clozapine":[8],"in":[9,15,36,140,191,201,232],"1990,":[10],"represented":[11],"an":[12],"important":[13],"advance":[14],"the":[16,80,106,122,152,189,222,226,233],"pharmacologic":[17],"treatment":[18,198,209,234],"schizophrenia.":[20,236],"However,":[21,148],"several":[22,134],"recent":[23],"comparative":[24,180,216],"effectiveness":[25],"trials":[26],"found":[27],"that":[28,121],"non-clozapine":[29],"SGAs":[30],"provided":[31],"little":[32],"or":[33,200],"no":[34],"advantage":[35],"efficacy":[37,128],"over":[38],"first-generation":[39],"antipsychotics,":[40],"and":[41,47,60,114,133,142,159,229],"all":[42],"agents":[43,124],"had":[44],"substantial":[45],"safety":[46,141],"tolerability":[48,143],"concerns.":[49],"Clearly,":[50],"there":[51],"remains":[52],"a":[53,93,150],"great":[54],"unmet":[55],"need":[56],"for":[57,96,211],"more":[58,196],"effective":[59],"better-tolerated":[61],"antipsychotics.":[62],"Relatively":[63],"potent":[64],"antagonism":[65,74],"serotonin":[67],"5-HT2A":[68],"receptors":[69,78],"coupled":[70],"with":[71,204],"relatively":[72],"weaker":[73],"dopamine":[76],"D2":[77],"is":[79],"central":[81],"pharmacological":[82],"characteristic":[83],"shared":[84],"most":[86],"SGAs.":[87],"This":[88],"profile":[89],"continues":[90],"to":[91,129,188,207,220],"be":[92,165],"favored":[94],"model":[95],"developing":[97],"new":[98],"SGAs,":[99],"commonly":[100],"defined":[101],"as":[102,149],"serotonin/dopamine":[103,131,154],"antagonists.":[104],"In":[105],"past":[107],"ten":[108],"years,":[109],"aripiprazole,":[110],"paliperidone,":[111],"asenapine,":[112],"iloperidone,":[113],"lurasidone":[115],"have":[116,125,172],"been":[117,175],"introduced.":[118],"Studies":[119],"suggest":[120],"newer":[123,153,227],"similar":[126],"short-term":[127],"earlier":[130],"antagonists,":[132],"demonstrate":[135],"at":[136],"least":[137],"modest":[138],"improvements":[139],"profiles,":[144],"particularly":[145],"metabolic":[146],"measures.":[147],"group,":[151],"antagonists":[155],"are":[156,218],"pharmacologically":[157],"heterogeneous,":[158],"their":[160,168,193,230],"side-effect":[161],"burden":[162],"can":[163],"still":[164],"considerable.":[166],"Moreover,":[167],"putative":[169],"clinical":[170],"advantages":[171],"not":[173],"yet":[174],"well":[176],"demonstrated":[177],"via":[178],"direct":[179],"studies.":[181],"absence":[183],"such":[185],"evidence":[186],"adds":[187],"challenges":[190],"defining":[192],"place":[194],"among":[195],"established":[197],"choices,":[199],"providing":[202],"clinicians":[203],"clear":[205],"indications":[206],"guide":[208],"choices":[210],"individual":[212],"patients.":[213],"Long-term,":[214],"head-to-head":[215],"studies":[217],"required":[219],"clarify":[221],"risk/benefit":[223],"profiles":[224],"roles":[231]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}